Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Koide

Showing results (331-340 of 342) with videos related to

Pageof 35
Sort By:
Human Molecular Genetics|November 5, 1999
Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD)E Kondo-Iida, K Kobayashi, M Watanabe, et al.
American Heart Journal|March 1, 1987
Detection of coronary artery disease with 13N-ammonia and high-resolution positron-emission computed tomographyY Yonekura, N Tamaki, M Senda, et al.
Biochemistry|January 11, 1994
Site-directed mutagenesis, fluorescence, and two-dimensional NMR studies on microenvironments of effector region aromatic residues of human c-Ha-Ras proteinK Yamasaki, M Shirouzu, Y Muto, et al.
Progress in Brain Research|January 1, 1991
Protein kinase C family and nervous functionY Nishizuka, M S Shearman, T Oda, et al.
Nihon Jinzo Gakkai Shi|August 1, 1993
Immunofluorescent analysis of extracellular matrix (ECM) components in glomeruli of the hepatic glomerulosclerosisY Tsushima, Y Tomino, L N Wang, et al.
Journal of Dental Research|July 5, 2002
Activation of adenosine-receptor-enhanced iNOS mRNA expression by gingival epithelial cellsS Murakami, N Yoshimura, H Koide, et al.
Nephron|January 1, 1997
Reduction of plasma nitric oxide in a patient with endotoxic shock by hemoadsorption therapyN Shimada, S Abe, T Hisiki, et al.
Oncogene|August 1, 1994
Mutations that abolish the ability of Ha-Ras to associate with Raf-1M Shirouzu, H Koide, J Fujita-Yoshigaki, et al.
Nihon Jinzo Gakkai Shi|June 1, 1982
[Effects of 1 alpha-(OH)D3 on renal osteodystrophy--a 5-year retrospective evaluation]T Kakuhara, M Mizoguchi, M Itoh, et al.
Clinical Pharmacology and Therapeutics|May 25, 2007
Model-based drug developmentR L Lalonde, K G Kowalski, M M Hutmacher, et al.
Pageof 35

Showing results (331-340 of 342) with videos related to

Sort By:
Pageof 35
Human Molecular Genetics|November 5, 1999
Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD)E Kondo-Iida, K Kobayashi, M Watanabe, et al.
American Heart Journal|March 1, 1987
Detection of coronary artery disease with 13N-ammonia and high-resolution positron-emission computed tomographyY Yonekura, N Tamaki, M Senda, et al.
Biochemistry|January 11, 1994
Site-directed mutagenesis, fluorescence, and two-dimensional NMR studies on microenvironments of effector region aromatic residues of human c-Ha-Ras proteinK Yamasaki, M Shirouzu, Y Muto, et al.
Progress in Brain Research|January 1, 1991
Protein kinase C family and nervous functionY Nishizuka, M S Shearman, T Oda, et al.
Nihon Jinzo Gakkai Shi|August 1, 1993
Immunofluorescent analysis of extracellular matrix (ECM) components in glomeruli of the hepatic glomerulosclerosisY Tsushima, Y Tomino, L N Wang, et al.
Journal of Dental Research|July 5, 2002
Activation of adenosine-receptor-enhanced iNOS mRNA expression by gingival epithelial cellsS Murakami, N Yoshimura, H Koide, et al.
Nephron|January 1, 1997
Reduction of plasma nitric oxide in a patient with endotoxic shock by hemoadsorption therapyN Shimada, S Abe, T Hisiki, et al.
Oncogene|August 1, 1994
Mutations that abolish the ability of Ha-Ras to associate with Raf-1M Shirouzu, H Koide, J Fujita-Yoshigaki, et al.
Nihon Jinzo Gakkai Shi|June 1, 1982
[Effects of 1 alpha-(OH)D3 on renal osteodystrophy--a 5-year retrospective evaluation]T Kakuhara, M Mizoguchi, M Itoh, et al.
Clinical Pharmacology and Therapeutics|May 25, 2007
Model-based drug developmentR L Lalonde, K G Kowalski, M M Hutmacher, et al.
Pageof 35